Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03953859 · ClinicalTrials.gov registry record

Embryo DNA Repair Capacity Project

A clinical trial of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
6
Enrollment target
1
Study location

NCT03953859 is a study of Infertility that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 6 participants, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03953859, a study of Infertility, has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
6 participants
Enrollment target
1
Study location

Study Summary

The mail aim of the present study is to use molecular methods to analyze the ability of human preimplantation embryos to repair their DNA

Conditions Studied

Interventions

  • GENETIC double strand break

Study Locations (1)

New Jersey

  • Reproductive Medicine Assoicates of New Jersey - Basking Ridge

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-04-04
Est. Completion 2021-12-09

What the Registry Record Tells You About NCT03953859

The ClinicalTrials.gov registry entry for NCT03953859 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which double strand break is the first listed.

NCT03953859 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03953859 about?

NCT03953859 is a clinical study titled "Embryo DNA Repair Capacity Project". The mail aim of the present study is to use molecular methods to analyze the ability of human preimplantation embryos to repair their DNA

What is the current status of trial NCT03953859?

This trial is currently completed. The enrollment target is 6 participants. The study started on 2019-04-04. Estimated completion is 2021-12-09.

What conditions does trial NCT03953859 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT03953859?

The interventions under investigation include: double strand break (GENETIC).

Who is sponsoring clinical trial NCT03953859?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03953859 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.